A Phase II Clinical Trial of KNP2002 (OM202JA)

Status:
Not yet recruiting

Trial end date:
2024-05-31

Target enrollment:

Participant gender:

The goal of this clinical trial is to evaluate safety and efficacy of KNP2002 in patients with common warts aged 15 to 50 years old.

Phase 2

KinoPharma Inc.